new_0222_0383|DAWN|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0383|DAWN|1|Day One Biopharmaceuticals Inc Total Current Assets (Quarterly) (USD)|Day One Biopharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|Day One Biopharmaceuticals Inc Inventories (Quarterly) (USD)|Day One Biopharmaceuticals Inc Net PP&E (Quarterly) (USD)|Day One Biopharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|Day One Biopharmaceuticals Inc Total Liabilities (Quarterly) (USD)|Day One Biopharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|Day One Biopharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|Day One Biopharmaceuticals Inc Total Deposits (Quarterly) (USD)|Day One Biopharmaceuticals Inc Book Value (Quarterly) (USD)|Day One Biopharmaceuticals Inc Retained Earnings (Quarterly) (USD)|Day One Biopharmaceuticals Inc Treasury Stock (Quarterly) (USD)|Day One Biopharmaceuticals Inc EV to Revenues|Day One Biopharmaceuticals Inc EV to Earnings|Day One Biopharmaceuticals Inc EV to Free Cash Flow|Day One Biopharmaceuticals Inc EV to Assets (Quarterly)|Day One Biopharmaceuticals Inc PS Ratio|Day One Biopharmaceuticals Inc PE Ratio|Day One Biopharmaceuticals Inc Price to Book Value|Day One Biopharmaceuticals Inc PEG Ratio|Day One Biopharmaceuticals Inc Debt to Equity Ratio|Day One Biopharmaceuticals Inc Dividend Yield|Day One Biopharmaceuticals Inc Shareholder Yield (TTM)|Day One Biopharmaceuticals Inc Percent of Shares Outstanding Short|Day One Biopharmaceuticals Inc Total Receivables (Quarterly) (USD)|Day One Biopharmaceuticals Inc Total Payables (Quarterly) (USD)|Day One Biopharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|Day One Biopharmaceuticals Inc Return on Invested Capital|Day One Biopharmaceuticals Inc Quality Ratio Score|Day One Biopharmaceuticals Inc Momentum Score|Day One Biopharmaceuticals Inc Beta (1Y)|Day One Biopharmaceuticals Inc Sustainable Growth Rate (TTM)|Day One Biopharmaceuticals Inc Institutional Investor Ownership Percentage|Day One Biopharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|Day One Biopharmaceuticals Inc Total Employees (Annual)|Day One Biopharmaceuticals Inc EPS Diluted (Quarterly) (USD)|Day One Biopharmaceuticals Inc Shares Outstanding|Day One Biopharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|Day One Biopharmaceuticals Inc Ordinary Shares Number (Quarterly)|Day One Biopharmaceuticals Inc Payout Ratio|Day One Biopharmaceuticals Inc Quick Ratio (Quarterly)|Day One Biopharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|Day One Biopharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|Day One Biopharmaceuticals Inc Effective Tax Rate (TTM)|Day One Biopharmaceuticals Inc Return on Equity|Day One Biopharmaceuticals Inc Net Income (TTM) (USD)|Day One Biopharmaceuticals Inc Revenue (TTM) (USD)|Day One Biopharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|Day One Biopharmaceuticals Inc Revenue (Quarterly) (USD)|Day One Biopharmaceuticals Inc Gross Profit (Quarterly) (USD)|Day One Biopharmaceuticals Inc SG&A Expense (Quarterly) (USD)|Day One Biopharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|Day One Biopharmaceuticals Inc Net Income (Quarterly) (USD)|Day One Biopharmaceuticals Inc Net Interest Income (Quarterly) (USD)|Day One Biopharmaceuticals Inc Price (USD)|Day One Biopharmaceuticals Inc Total Return Price (USD)|Day One Biopharmaceuticals Inc Enterprise Value (USD)|Day One Biopharmaceuticals Inc 30-Day Average Daily Volume|Day One Biopharmaceuticals Inc 1 Year Price Returns (Daily)||
new_0222_0383|DAWN|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0383|DAWN|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly||
new_0222_0383|DAWN|5|91|91|0|91|0|91|91|91|0|91|91|0|0|0|1.44565217391|0|0|0|1.43827160494|0|0|1.44565217391|0|15.5|0|91|91|0|0|0|0|0|30.625|91.3333333333|183|91.3333333333|26.6666666667|0|91|0|0|91.3333333333|91.4|0|0|91|0|0|0|0|91.3333333333|91.3333333333|91.3333333333|91.3333333333|1.44324324324|1.44324324324|1.44565217391|1.43870967742|0||
new_0222_0383|DAWN|6|3|3|0|3|0|3|3|3|0|3|3|0|0|0|184|0|0|0|162|0|0|184|0|16|0|3|3|0|0|0|0|0|8|6|1|6|6|0|3|0|0|6|5|0|0|3|0|0|0|0|6|6|6|6|185|185|184|155|0||
new_0222_0383|DAWN|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0383|DAWN|202003||||||||||||||||||||||||||||||||||42.031||-0.0365||||||-0.0313|||||||||0.808|-1.992|-1.535|-0.003|||||||
new_0222_0383|DAWN|202006||||||||||||||||||||||||||||||||||42.031||-0.0419||||||-0.0397|0||||||||0.872|-2.409|-1.76|-0.01|||||||
new_0222_0383|DAWN|202009||||||||||||||||||||||||||||||||||42.031||-0.0672||||||-0.0607|0||||||||1.024|-3.842|-2.824|-0.009|||||||
new_0222_0383|DAWN|202012|45.071|43.728||0.483||94.164|1.996|97.87||-54.205|-56.842|||||||||||||||0.202|2|||||||42.031||-0.8179|||60.3374|||-0.1179||||-40.496|||||1.979|-35.6|-34.377|-0.008|||||||
new_0222_0383|DAWN|202103|158.755|154.87||0.435||224.946|3.066|226.663||-68.849|-72.024||||-43.7958|||||||0||0||0.686|2||||||12.8073|42.031|20|-0.2516|60.4289||60.3374|||-0.38||||-54.143|||||3.454|-16.101|-15.182|-0.007|25.89|25.89|1414.4172||||
new_0222_0383|DAWN|202106|316.025|309.996||0.386||4.774|4.662|0.112||311.763|-86.308||||-27.054||||4.5231|||0||1.4606||0.348|0.006||||||65.4663|22.6619||-5.04|61.9289||61.9289|||-5.04|-167.66|||-66.665|||||5.525|-15.473|-14.282|-0.007|20.14|20.14|1097.161|68905.2667||23.28|27.51
new_0222_0383|DAWN|202109|303.311|297.16||0.335||6.111|6.046|0.065||297.672|-105.548||||-23.7778||||4.7376|||0||2.8738||0.683|0.006||||||64.6029|57.5142|42|-0.33|61.9289||61.9289|||-0.33|0.615|||-83.081|||||9.392|-19.24|-19.24|-0.006|23.85|23.85|1172.4128|160855.6667||22.24|18.16
new_0222_0383|DAWN|202112||284.309||||8.673|||||||||-15.1366||||3.4015|||0||5.5587|||||||||68.5642|||-0.3541|61.9523|||||||||-70.642|||||10.786||-21.938||16.35|16.35|691.8445|293887.7667||13.85|13.42
new_0222_0383|DAWN|202203||262.731||||8.176|||||||||||||2.1678|||||||||||||||||-0.48|61.9119|||||||||-83.207|||||12.745||-27.747||9.83|9.83|312.751|232203.3667||9.02|5.72
new_0222_0383|DAWN|202206||394.864||||13.416|||||||||||||4.9629|||||||||||||||||-0.6|73.4611||||||-161.61|||-105.455|||||14.159||-36.53||17.78|17.78|1042.5326|3046442.9667||17.13|24.09
new_0222_0383|DAWN|202209||374.341||||18.785|||||||||||||3.7818|||||||||||||||||-0.53|73.5119|||||||||-124.01|||||17.664||-37.795||20.03|20.03|1098.1024|783517.6667||21.35|21.41
new_0222_0383|DAWN|202212||342.269||||17.023|||||||||||||4.013|||||||||||||||||-0.56|73.4582|||||||||-142.181|||||16.723||-40.109||21.52|21.52|1208.4442|440141.2333||21.45|17.99
new_0222_0383|DAWN|202303||318.179||||23.148|||||||||||||2.8811|||||||||||||||||-0.59|73.5726|||||||||-156.827|||||18.027||-42.393||13.37|13.37|665.4867|697149.9||13.71|12.02
new_0222_0383|DAWN|202306||442.882||||24.702|||||||||||||3.6394|||||||||||||||||-0.61|86.9713||||||-161.409|||-166.16|||||17.072||-45.863||11.83|11.83|709.1607|1721915.3667||12.13|13.35
new_0222_0383|DAWN|202309||405.538||||24.552|||||||||||||2.5538|||||||||||||||||-0.54|87.0429|||||||||-174.515|||||18.275||-46.15||12.51|12.51|645.1602|793489.5333||9.85|11.6
new_0222_0383|DAWN|202312||366.347||||29.508|||||||||||||3.3778|||||||||||||||||-0.64|87.2271|||||||||-188.917|||||22.169||-54.511||15.12|15.12|910.5506|590089.6||15.05|16.83
new_0222_0383|DAWN|202403||317.944||||29.839|||||||||||||3.9813|||||||||||||||||-0.72|87.3772|||||||||-208.936|||||26.557||-62.412||15.79|15.79|1013.339|744907.2667||15.19|13.76
new_0222_0383|DAWN|202406||361.866||||93.706|||||||||||||4.072|||||||||||||||||-0.05|87.6929|||||||||-167.48|||8.192|7.485|30.186||-4.407||13.83|13.83|890.6583|885884.1333||16.03|13.84
new_0222_0383|DAWN|202409||558.383||||45.344|||||||||||||4.5385|||||||||||||||||0.38|100.8104||||||-178.177|||-84.293|||93.761|92.171|28.972||37.037||14.16|14.16|1030.2348|834032.4||14.6|13.93
new_0222_0383|DAWN|202412||531.72||||80.037|||||||||||||2.3366|||||||||||||||||-0.69|101.1162|||||||||-95.496|||29.208|26.226|29.735||-65.714||12.87|12.87|739.5089|991577.7667||12.37|9.06
new_0222_0383|DAWN|202503||473.02||||54.844|||||||||||4.7653||1.6269|||||||||||||||||-0.35|101.3538|||||||||-69.08|161.922||30.761|27.877|29.325||-35.996||8.07|8.07|286.2052|1327159.2667||7.74|6.3
new_0222_0383|DAWN|202506|||||||||||||||||3.906||1.3677||||||||||||||||||||||||||||||||||||6.48|6.48|183.809|1315098.2333||6.8|